NASDAQ

– USA, CA –  Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced the appointment of David Moore to its Board of Directors, bringing a wealth of experience from his 27-year career in the industry, including broad expertise across strategy, commercial, market access, business development and investing from working in both large cap pharmaceutical and biotech companies and within private equity.…

– USA, MA –  Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, announced the appointment of Brian Posner to its Board of Directors, bringing 35 years of executive, investment, and board leadership expertise to the company.…